Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients
Clinical trial NCT04353973 · COMPLETED
Trial details
- NCT number
- NCT04353973
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2024-08-15
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.